VT News

Pascal Guyot

Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making it a top performer in the S&P 500 and Nasdaq 100.
  • Colts QB Richardson's injury raises durability concerns as analysts criticize his decision-making.
  • Trump deploys federal officers to patrol Washington D.C. amid rising crime, sparking concerns over federal intervention and community trust.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making it a top performer in the S&P 500 and Nasdaq 100.
  • Colts QB Richardson's injury raises durability concerns as analysts criticize his decision-making.
  • Trump deploys federal officers to patrol Washington D.C. amid rising crime, sparking concerns over federal intervention and community trust.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Pascal Guyot

Top Topics

Trending in U.S.

World

Sport